Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in canadian inuit children: A case-control study

Pediatric Infectious Disease Journal

Volumn 28, Issue 8, 2009, Pages 697-701

  Banerji, Anna ^a   Greenberg, David ^b   White, Laura Forsberg ^c   MacDonald, W Alexander ^d   Saxton, Audrey ^e   Thomas, Eva ^f   Sage, Douglas ^d   Mamdani, Muhammad ^g   Lanctôt, Krista L ^h   Mahony, James B ⁱ   Dingle, Mia ^e   Roberts, Ann ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d Government of Nunavut   (Canada)

^e Baffin Regional Hospital   (Canada)

^f BC CHILDREN S HOSPITAL   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

Author keywords

Crowding; Inuit; Lower respiratory tract infections; Rural; Smoking

Indexed keywords

ARTICLE; BREAST FEEDING; CHILD; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NASOPHARYNGEAL ASPIRATION; NEWBORN; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; VIRUS INFECTION;

EID: 68649103298     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31819f1f89     Document Type: Article

References (46)

1. Banerji A. High rates of hospitalisation for bronchiolitis in Inuit children on Baffin Island. Int J Circumpolar Health. 2001;60:375-379.
2. Banerji A, Bell A, Mills EL, et al. Lower respiratory tract infections in Inuit infants on Baffin Island. CMAJ. 2001;164:1847-1850.
3. Carson JB, Postl BD, Spady D, et al. Lower respiratory tract infections among Canadian Inuit Children. Int J Circumpolar Health. 1984;84:226-228.
4. Creery D, Lyer P, Samson L, et al. Costs associated with infant bronchiolitis in the Baffin region of Nunavut. Int J Circumpolar Health. 2005;64:38-45.
5. Banerji A, Lanctot KL, Paes B, et al. Comparison of the cost of respiratory syncytial virus hospitalization versus palivizumab prophylaxis in term Canadian Inuit Infants. Pediatr Infect Dis J. 2009;28:702-706.
6. Figueras-Aloy J, Carbonell-Estrany X, Quero J. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J. 2004;23:815-820.
7. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23:806-814.
8. Meissner HC, Rennels MB, Pickering LK, et al. Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab. Pediatr Infect Dis J. 2004;23: 284-285.
9. Bulkow LR, Singleton RJ, Karron RA, et al. Risk factors for severe respiratory syncytial virus infection among Alaska native children. Pediatrics. 2002;109:210-216.
10. Koch A, Molbak K, Homoe P, et al. Risk factors for acute respiratory tract infections in young Greenlandic children. Am J Epidemiol. 2003;158:374-384.
11. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3 Pt 1):531-537.
12. Wang EE, Law BJ, Boucher FD, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1996;129:390-395.
13. Young M, Kandola K, Mitchell R, et al. Hospital admission rates for lower respiratory tract infections in infants in the Northwest Territories and Kitikmeot region of Nunavut for 2000-2004. Paediatr Child Health. 2007;12:563-566.
14. Statistics Canada. 2001 Community Profiles. Catalogue No. 93F0053XIE. Last modified: November 30, 2005.
15. Statistics Canada. 2001 Age Groups (12) and Sex (3) for Population, for Canada, Provinces and Territories, 1921 to 2001 Censuses - 100% Data. Catalogue No: 97F0003XCB2001002.
16. Mahony J, Chong S, Merante F, et al. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J Clin Microbiol. 2007;45:2965-2970.
17. Mahony J, Chong S, Smieja M, et al. Establishing the epidemiology of respiratory virus infections using molecular technology. Presented at: 107th Annual Meeting of the American Society for Microbiology; May 2007; Toronto, Canada. Abstract C-070.
18. Fleshman JK, Wilson JF, Cohen JJ. Bronchiectasis in Alaska Native children. Arch Environ Health. 1968;17:517-523.
19. Beaudry PH. Pulmonary function survey of the Canadian Eastern Arctic Eskimo. Arch Environ Health. 1968;17:524-528.
20. Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol. 2000;29:182-187.
21. Hemmelgarn B, Ernst P. Airway function among Inuit primary school children in far northern Quebec. Am J Respir Crit Care Med. 1997;156: 1870-1875.
22. Bulterys M. High incidence of sudden infant death syndrome among northern Indians and Alaska natives compared with southwestern Indians: possible role of smoking. J Community Health. 1990;15:185-194.
23. Hoffman HJ, Hillman LS. Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postneonatal risk factors. Clin Perinatol. 1992;19:717-737.
24. Haglund B, Cnattingius S. Cigarette smoking as a risk factor for sudden infant death syndrome: a population-based study. Am J Public Health. 1990;80:29-32.
25. Hall CB, Hall WJ, Gala CL, et al. Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr. 1984;105:358-364.
26. Singleton R. Association between maternal smoking and severe respiratory syncytial virus infections and sudden infant death syndrome. Alaska Med. 1996;38:34.
27. Culman KN, Ward BJ, Pekeles GS, et al. Comparison of immune cell phenotypes in Inuit and non-Inuit Canadian infants. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, CA. Abstract 2172.
28. Pekeles GS, Aouchiche S, Johns TM, et al. Differences in costimulatory molecules on peripheral blood mononuclear cells in Inuit and non-Inuit Canadian infants. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco, CA. Abstract 2173.
29. Moore H, Burgner D, Carville K, et al. Diverging trends for lower respiratory infections in non-Aboriginal and Aboriginal children. J Paediatr Child Health. 2007;43:451-457.
30. Bjerregaard P. Infant mortality in Greenland. Arctic Med Res. 1986;42: 10-17.
31. Lowther SA, Shay DK, Holman RC, et al. Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. Pediatr Infect Dis J. 2000;19:11-17.
32. Evers S, Orchard J, McCracken E. Lower respiratory disease in Indian and non-Indian infants. Can J Public Health. 1985;76:195-198.
33. Evers SE, Rand CG. Morbidity in Canadian Indian and non-Indian children in the first year of life. Can Med Assoc J. 1982;126:249-252.
34. Evers SE, Rand CG. Morbidity in Canadian Indian and non-Indian children in the second year. Can J Public Health. 1983;74:191-194.
35. Houston CS, Weiler RL, Habbick BF. Severity of lung disease in Indian children. Can Med Assoc J. 1979;120:1116, 1119, 1121.
36. Koehoorn M, Karr CJ, Demers PA, et al. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics. 2008;122: 1196-1203.
37. Government of Quebec NRBoHaSS. Nunavik Population Categorized by Age Group (1996). Available at: http://www.rrsss17gouvqcca/en/nunavik/ demographieaspx. 2003.
38. Jenkins AL, Gyorkos TW, Joseph L, et al. Risk factors for hospitalization and infection in Canadian Inuit infants over the first year of life-a pilot study. Int J Circumpolar Health. 2004;63:61-70.
39. Singleton RJ, Petersen KM, Berner JE, et al. Hospitalizations for respiratory syncytial virus infection in Alaska Native children. Pediatr Infect Dis J. 1995;14:26-30.
40. Jenkins AL, Gyorkos TW, Culman KN, et al. An overview of factors influencing the health of Canadian Inuit infants. Int J Circumpolar Health. 2003;62:17-39.
41. Holman RC, Curns AT, Cheek JE, et al. Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics. 2004;114:e437-e444.
42. Bjerregaard P, Misfeldt J. Infant mortality in Greenland: secular trend and regional variation. Arctic Med Res. 1992;51:126-135.
43. Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112(6 Pt 1): 1442-1446.
44. National Advisory Committee on Immunization. Statement on the recommended use of monoclonal anti-RSV antibody (palivizumab). Can Commun Dis Rep. 2003;29:1-15.
45. Staat MA. Respiratory syncytial virus infections in children. Semin Respir Infect. 2002;17:15-20.
46. Bonzel L, Tenenbaum T, Schroten H, et al. Frequent detection of viral coinfection in children hospitalized with acute respiratory tract infection using a real-time polymerase chain reaction. Pediatr Infect Dis J. 2008;27: 589-594.